Oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide, preparation method and applications thereof

A technology of Streptococcus pneumoniae and capsular polysaccharides, which is applied in the direction of medical preparations containing active ingredients, antibacterial drugs, drug combinations, etc., can solve problems such as poor biocompatibility, unpredictable impact of biological activity, and different effects. To achieve the effect of promoting antibody maturation

Active Publication Date: 2017-10-03
SHANDONG UNIV
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This type of conjugate vaccine has several disadvantages: (1) the capsular polysaccharide obtained by crushing the bacteria is not a single substance, and the length of the capsular polysaccharide sugar chain is different; (2) it is inevitable in the process of extracting the capsular polysaccharide (3) The effect of each batch of conjugated vaccines may be different, with microscopic inhomogeneity, and the product quality is difficult to control
However, since the carrier molecule is a type of small molecular compound - glycosphingolipids, its biocompatibilit

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide, preparation method and applications thereof
  • Oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide, preparation method and applications thereof
  • Oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide, preparation method and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1: general synthetic method

[0043] A: Benzoylation reaction

[0044] Get the raw material (1 mass part) and dissolve in pyridine, add benzoyl chloride solution (2.2 mass parts) under stirring condition, stir at room temperature for 2 hours, as the reaction proceeds, white solid is constantly separated out, concentrated, recrystallized, Filter to obtain a white solid product;

[0045] B: 4,6-position benzylidene transposition reaction

[0046] Take raw material (1 gram) and dissolve in dry 15 milliliters of dichloromethane, under the conditions of 0 ℃ and nitrogen protection, add triethylsilane (5 mass parts) and trifluoroacetic acid (5 mass parts), stir reaction 2 After 1 hour, dilute the reaction solution with 20 ml of dichloromethane, wash and extract with saturated aqueous sodium bicarbonate solution 3 times, take the lower organic phase, dry with anhydrous sodium sulfate, filter, concentrate, and separate with silica gel column chromatography. Deliqu...

Embodiment 2

[0056] Example 2: 3-aminopropyl β-D-glucosyl-(1→3)-β-D-glucosyl-(1→4)-β-D-glucosyl-(1→3)-β Synthesis of -D-glucosyl acid-(1→4)-β-D-glucose-TT conjugate (A17-TT)

[0057] (1) Synthesis of p-tolylthio 2,3,4,6-tetra-oxo-acetyl-1-thio-β-D-glucose (A1)

[0058]

[0059] Take β-D-full acetyl sugar (10.0g, 25.6mmol) and p-cresol (3.8g, 30.6mmol), after drying, dissolve in 50mL of dry dichloromethane, and add 10mL of Boron trifluoride ether solution, react at room temperature for 3 to 4 hours, TLC (PE:EA=1:2) to detect the reaction situation, until the raw materials no longer decrease, dilute the reaction solution with an appropriate amount of dichloromethane, and dilute the reaction solution with saturated NaHCO 3 After the aqueous solution was washed and extracted 3 times, the organic phase of the lower layer was removed and washed with anhydrous Na 2 SO 4 Dry, filter, concentrate, and separate by silica gel column chromatography to obtain compound A1 (10.0 g, yield 86%).

[...

Embodiment 3

[0112] Example 3: 3-Aminopropyl β-D-glucosyl-(1→4)-β-D-glucosyl-(1→3)-β-D-glucosyl-(1→4)- Synthesis of β-D-glucosyl-(1→3)-β-D-glucosyl-(1→4)-β-D-glucose-TT conjugate (B5-TT)

[0113] (1) 3-Azidopropyl 2,3-di-oxo-benzoyl-4,6-oxo-benzylidene-β-D-glucosyl-(1→4)-2,3-di- Synthesis of Oxy-benzoyl-6-oxo-benzyl-1-thio-β-D-glucose (B1)

[0114]

[0115] Using A4 (634.2 mg, 1.09 mmol) as the glycosyl donor and A5 (511.9 mg, 0.88 mmol) as the glycosyl acceptor, the target product B1 (676 mg, Yield 74%).

[0116] (2) 3-Azidopropyl 2,3-di-benzoyl-4,6-oxo-benzylidene-β-D-glucosyl-(1→4)-2,3-di-benzoyl Acyl-6-oxo-benzyl-β-D-glucosyl-(1→3)-2-oxo-benzoyl-4,6-oxo-benzylidene-β-D-glucosyl-(1→4 )-2,3-di-oxo-benzoyl-6-oxo-benzyl-β-D-glucosyl-(1→3)-2-oxo-benzoyl-4,6-oxo-benzyl Synthesis of -β-D-glucosyl-(1→4)-2,3-di-oxo-benzoyl-6-oxo-benzyl-1-thio-β-D-glucose (B2)

[0117]

[0118] Take B1 (355.6mg, 0.34mmol) as the glycosyl donor, A13 (491.9mg, 0.28mmol) as the glycosyl acceptor, carry ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to an oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide, a preparation method and applications thereof, wherein the structure general formula of the oligosaccharide conjugate is defined in the specification. According to the present invention, the system of the Streptococcus pneumoniae type 3 capsular polysaccharide related oligosaccharide derivative is firstly discloses, and can be used for preparing a novel oligosaccharide-protein binding vaccine against Streptococcus pneumoniae type 3.

Description

technical field [0001] The invention relates to an oligosaccharide conjugate based on Streptococcus pneumoniae type 3 capsular polysaccharide and its preparation method and application, belonging to the technical field of Streptococcus pneumoniae vaccine development. Background technique [0002] Streptococcus pneumoniae is a Gram-positive diplococcus first isolated in 1881 by both US Army physician George Sternberg and French chemist Louis Pasteur. It often lives in the nasopharyngeal cavity of people, and can cause respiratory tract infection and lung infection. In severe cases, it can cause diseases such as meningitis, otitis media, and sepsis. Nearly 1 million children under the age of 5 die from these diseases every year in developing countries, and the prevention and treatment of these infectious diseases requires a lot of financial resources. [0003] There is a thick layer of sugar coating on the surface of Streptococcus pneumoniae, which can reduce the influence of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/09A61K39/385A61P31/04A61P11/00
CPCA61K39/092A61K39/385A61K2039/575A61K2039/6018A61K2039/6037A61K2039/6081A61K2039/627
Inventor 顾国锋熊成鹤郭忠武冯少杰乔银
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap